Skip to Main Content
IBM System Storage Ideas Portal


This portal is to open public enhancement requests against IBM System Storage products. To view all of your ideas submitted to IBM, create and manage groups of Ideas, or create an idea explicitly set to be either visible by all (public) or visible only to you and IBM (private), use the IBM Unified Ideas Portal (https://ideas.ibm.com).


Shape the future of IBM!

We invite you to shape the future of IBM, including product roadmaps, by submitting ideas that matter to you the most. Here's how it works:

Search existing ideas

Start by searching and reviewing ideas and requests to enhance a product or service. Take a look at ideas others have posted, and add a comment, vote, or subscribe to updates on them if they matter to you. If you can't find what you are looking for,

Post your ideas
  1. Post an idea.

  2. Get feedback from the IBM team and other customers to refine your idea.

  3. Follow the idea through the IBM Ideas process.


Specific links you will want to bookmark for future use

Welcome to the IBM Ideas Portal (https://www.ibm.com/ideas) - Use this site to find out additional information and details about the IBM Ideas process and statuses.

IBM Unified Ideas Portal (https://ideas.ibm.com) - Use this site to view all of your ideas, create new ideas for any IBM product, or search for ideas across all of IBM.

ideasibm@us.ibm.com - Use this email to suggest enhancements to the Ideas process or request help from IBM for submitting your Ideas.

Status Submitted
Created by Guest
Created on Nov 22, 2026

A 40 Hz Gamma Entrainment Trial Record

PROBLEM: 40 Hz light-and-sound stimulation is being tested as a way to entrain gamma brain oscillations in Alzheimer's disease, and early results are quoted as if the therapy were established — but the trials are small, early, and not FDA-cleared, so quoting them without the trial record overstates what is known.

SOLUTION: A 40 Hz gamma entrainment trial record that logs each trial's design, sample size, outcomes, and regulatory status, and records the current state plainly: early-stage trials with reported cognitive improvement, awaiting replication, not FDA-cleared.

EVIDENCE BASIS: REPORTED — Cognito Therapeutics' Spectris (40 Hz light + sound) and related 40 Hz vibroacoustic approaches are in early trials; one 8-week trial reported cognitive improvement and reduced depressive symptoms in the 40 Hz group. Not FDA-cleared; replication pending.

Idea priority Low